Status:

COMPLETED

Study of the Resvent RXiBreeze™ PAP System to Treat Obstructive Sleep Apnea

Lead Sponsor:

Resvent Holding USA LTD

Collaborating Sponsors:

Avania

Resvent Medical Technology Co., Ltd.

Conditions:

Obstructive Sleep Apnea

Eligibility:

All Genders

22+ years

Phase:

NA

Brief Summary

The goal of this clinical trial is to test the automatic positive airway pressure (APAP) function of the RXiBreeze PAP System in adult subjects with obstructive sleep apnea (OSA). The main questions t...

Detailed Description

This is a prospective, multicenter, single-arm trial designed to evaluate the safety and effectiveness of the RXiBreeze PAP System to treat obstructive sleep apnea and detect breathing events. Eligibl...

Eligibility Criteria

Inclusion

  • Subject is ≥ 22 years old
  • Subject has been diagnosed with OSA (as scored per AASM scoring guidelines) and has an AHI ≥ 10, based on the results of a sleep study conducted at an accredited sleep lab, within 30 days prior to enrollment
  • Subject weighs \>30 kg
  • Subject has been prescribed the use of an Auto CPAP system
  • Subject agrees to fulfill all study-required tests, sleep lab session attendance, and assessments
  • Subject agrees to use the RXiBreeze PAP System as prescribed
  • Subject is willing and able to provide informed consent

Exclusion

  • Subject has been diagnosed with a sleep disorder other than OSA
  • Subject's Central Apnea Index from the baseline PSG is \> 20% of AHI
  • Subject has been diagnosed with severe (stage 3) coronary artery disease
  • Subject has been diagnosed with bullous lung disease
  • subject has been diagnosed with hypotension
  • subject has been diagnosed with bypassed upper airway pneumothorax
  • Subject is pregnant, breastfeeding, or planning on becoming pregnant during trial participation
  • Subject, in the opinion of the investigator, is not suitable for trial participation

Key Trial Info

Start Date :

August 22 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 29 2023

Estimated Enrollment :

146 Patients enrolled

Trial Details

Trial ID

NCT06008678

Start Date

August 22 2023

End Date

November 29 2023

Last Update

December 2 2024

Active Locations (9)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (9 locations)

1

Peninsula Sleep Center

Burlingame, California, United States, 94010

2

Exalt Clinical Research

Chula Vista, California, United States, 91910

3

Bay Sleep Clinic

Mountain View, California, United States, 94040

4

Innovative Sleep Centers, Inc.

Redding, California, United States, 96003

Study of the Resvent RXiBreeze™ PAP System to Treat Obstructive Sleep Apnea | DecenTrialz